The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes to worsening metabolic health and an increased risk of type 2 diabetes.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

The incretin-based therapies reduced mortality and hospitalization risk in individuals with heart failure with preserved ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Some 20 weeks after stopping their drugs, the participants in the studies had put back on an average of 2.5 kilograms (5.5 ...

A new Mounjaro user has opened up on their experience taking the drug - including the one side effect they're struggling with ...

The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.